首页> 美国政府科技报告 >Enhancing the Immunogenicity of a Dengue-2 DNA Vaccine with Adjuvants and Anti-Fc(gamma)RI Antibodies
【24h】

Enhancing the Immunogenicity of a Dengue-2 DNA Vaccine with Adjuvants and Anti-Fc(gamma)RI Antibodies

机译:用佐剂和抗Fc(γ)RI抗体增强登革2型DNa疫苗的免疫原性

获取原文

摘要

The objective is to use adjuvants to enhance the immunogenicity of a dengue (DEN) DNA vaccine. The adjuvants to be evaluated in this project include aluminum phosphate, tetanus toxoid and anti-Fc(gamma)R monoclonal antibodies chemically linked to the DNA vaccine. Multiple attempts to link the anti- Fc(gamma)R monoclonal antibody to the DNA vaccine resulted in a poor efficiency in the linkage reaction using thiol linkage chemistry. An alternative approach using hydrazine and aldehyde linkage methods is currently being pursued. Experiments were initiated to evaluate the ability of tetanus toxoid (TT) to enhance the immunogenicity of the DEN DNA vaccine. The antibody responses to the vaccine given IM were enhanced slightly by combining it with TT. However, the ELISA and neutralizing doses of the vaccine given by Biojector, TT appeared to have an inhibitory effect. Aluminum Phosphate was demonstrated to slightly enhance anti-dengue neutralizing antibody responses, only when the DNA vaccine was given ID at suboptimal doses. There was essentially no effect when the vaccine was administered IM.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号